{"organizations": [], "uuid": "389ed79b35f2114b71eaa85ca68a321fc177ad81", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/jazz-phrmt-settlement/jazz-pharmaceuticals-to-settle-u-s-probe-for-57-million-idUSL1N1SF2OO", "country": "US", "domain_rank": 408, "title": "Jazz Pharmaceuticals to settle U.S. probe for $57 million", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-09T02:15:00.000+03:00", "replies_count": 0, "uuid": "389ed79b35f2114b71eaa85ca68a321fc177ad81"}, "author": "", "url": "https://www.reuters.com/article/jazz-phrmt-settlement/jazz-pharmaceuticals-to-settle-u-s-probe-for-57-million-idUSL1N1SF2OO", "ord_in_thread": 0, "title": "Jazz Pharmaceuticals to settle U.S. probe for $57 million", "locations": [], "entities": {"persons": [{"name": "nate raymond", "sentiment": "none"}, {"name": "sandra maler", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "boston", "sentiment": "none"}, {"name": "boston", "sentiment": "none"}], "organizations": [{"name": "jazz pharmaceuticals", "sentiment": "negative"}, {"name": "medicare", "sentiment": "none"}, {"name": "u.s. justice department", "sentiment": "none"}, {"name": "jazz pharmaceuticals plc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "u.s. securities and exchange commission", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "BOSTON, May 8 (Reuters) - Jazz Pharmaceuticals plc on Tuesday said that it had agreed to pay $57 million to resolve a U.S. probe into its financial support of charities that offer assistance to Medicare patients seeking help to cover out-of-pocket drug costs.\nThe drugmaker in a filing with the U.S. Securities and Exchange Commission said that it reached an agreement in principle with the U.S. Justice Department to pay the sum as part of a civil settlement. (Reporting by Nate Raymond in Boston; Editing by Sandra Maler)\n ", "external_links": [], "published": "2018-05-09T02:15:00.000+03:00", "crawled": "2018-05-09T02:36:41.000+03:00", "highlightTitle": ""}